Pseudomonas fluorescens CRBSI outbreak: complying with the standardization of invasive procedures is a step ahead in the fight against antimicrobial resistance

Table 1 Patient characteristics during the CR P. fluorescens CRBSI outbreak in chronological order of CVC insertion date

Patient	Number of CRBSI per patient	Age	Sex	Diagnosis	Date^a of CVC insertion	Date^a of blood culture withdrawal	Time to positivity of blood culture (hours)
1	1	78	Male	ALL/LBL	21/06/2022	15/07/2022	64
2	1	33	Female	AML	27/06/2022	16/07/2022	12
3	1	33	Female	AML	13/07/2022	15/07/2022	20
4	1	79	Male	DLBCL	15/07/2022	26/07/2022	24
5	1	74	Female	HL	19/07/2022	27/07/2022	24
3	2	33	Female	AML	27/07/2022	27/07/2022	12

ALL/LBL Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma, AML Acute Myeloid Leukemia, DLBCL Diffuse Large B-Cell Lymphoma, HL Hodgkin’s lymphoma
^aDates are presented in dd/mm/yyyy format

ISSN: 2047-2994